Fourth Annual NYU Langone Advanced Seminar in Psoriasis and Psoriatic Arthritis is organized by New York University (NYU) School of Medicine and will be held on Dec 07, 2018 at NYU Langone Health, New York City, New York, United States of America.
The target audience for this medical event is Clinical and academic rheumatologists, dermatologists, orthopedists, trainees in the rheumatic/dermatologic diseases, internists, and other health care professionals with a special interest in psoriasis and psoriatic arthritis. This CME Conference has been approved for a maximum of 8.5 AMA PRA Category 1 Credits and 8.5 MOC Points.
Conference Description :
The NYU Seminar in Psoriasis and Psoriatic Arthritis will review and address those areas where recent, solid knowledge in the treatment of psoriasis, psoriatic arthritis, and related conditions is available, focusing particularly on the state-of-the-art in the field, at the leading edge between new clinical knowledge and its translation into practice. Rheumatology and dermatology, and specifically psoriasis and psoriatic arthritis, are fast-moving fields in which new discoveries are continually being made, and new treatment modalities developed. Because the basic and clinical scientific underpinnings of rheumatologic-dermatologic practice frequently and directly come to impact upon therapy, this course will also explore those areas of new science that are likely to prove important to the near-future management of patients with psoriasis and psoriatic arthritis. Lectures and year-in-review updates will provide participants with the latest information in psoriasis, psoriatic arthritis and other related conditions; panel discussions and optional meet-the-professor sessions will allow participants to raise questions and participate in dialog with the course instructors and clinical experts.
Conference Objectives are :
• Recognize the benefits, and manage risks of newly available biologic therapies for treatment of psoriasis and psoriatic arthritis and develop strategies to determine when to introduce small-molecule biological therapies into treatment.
• Recognize signs and symptoms suggest psoriatic arthritis in patients with psoriasis, describe current screening tools for psoriatic arthritis, and recognize the benefits of early recognition and treatment of psoriatic arthritis.
• Identify key cytokine and inflammatory pathways in psoriasis and psoriatic arthritis and identify how side effect profiles of various therapeutic agents may be related to specific immune pathways affected by various treatments and downstream effects.
|Contact No. :||212.263.5295
|Registration Type||End Date||Price|
|Full Fee||04 Dec,2018||USD 100.00|
|Onsite Fee||07 Dec,2018||USD 120.00|
|Physicians-in-training, Physicians employed by the Department of Veterans Affairs Medical Center, full-time active military personnel, retired physicians, advanced practice providers, and all other Nonphysician healthcare professionals Fee||06 Dec,2018||USD 75.00|